313 related articles for article (PubMed ID: 15250020)
21. [Antimicrobial therapy of febrile neutropenia--current developments].
Karthaus M; Cornely OA; Südhoff T; Meran J
Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
[TBL] [Abstract][Full Text] [Related]
22. [Antibiotic therapy in leukopenia].
Böhme A; Shah PM; Stille W; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1120-5. PubMed ID: 9782739
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
[TBL] [Abstract][Full Text] [Related]
24. [Infections in neutropenic patients].
Berenguer J
Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
[No Abstract] [Full Text] [Related]
25. Empirical antifungal therapy in treating febrile neutropenic patients.
Wingard JR
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic procedures and management of Fever in pediatric cancer patients].
Laws HJ; Ammann RA; Lehrnbecher T
Klin Padiatr; 2005 Nov; 217 Suppl 1():S9-16. PubMed ID: 16288350
[TBL] [Abstract][Full Text] [Related]
27. Empirical therapy of infections in neutropenic patients.
Gaya H
Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
[No Abstract] [Full Text] [Related]
28. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
Ramphal R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
[TBL] [Abstract][Full Text] [Related]
29. Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Fleming DR; Ziegler C; Baize T; Mudd L; Goldsmith GH; Herzig RH
Am J Clin Oncol; 2003 Jun; 26(3):285-8. PubMed ID: 12796602
[TBL] [Abstract][Full Text] [Related]
30. Empiric therapy for febrile neutropenia: what are the choices?
Aoun M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
[TBL] [Abstract][Full Text] [Related]
31. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification.
Viscoli C; Varnier O; Machetti M
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S240-5. PubMed ID: 15768329
[TBL] [Abstract][Full Text] [Related]
32. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
33. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
Corey AL; Snyder S
J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
[TBL] [Abstract][Full Text] [Related]
34. Managing infections in the immunocompromised patient.
Bodey GP
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S239. PubMed ID: 15768328
[TBL] [Abstract][Full Text] [Related]
35. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S11-4. PubMed ID: 15250015
[TBL] [Abstract][Full Text] [Related]
36. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
37. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
38. Economic issues: toward a cost-effective approach to the management of febrile neutropenia in Japan.
Masaoka T
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S68-9. PubMed ID: 15250026
[TBL] [Abstract][Full Text] [Related]
39. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
40. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]